Home » Topics » BioWorld Science

BioWorld Science
RSS

ViiV Healthcare UK describes HIV integrase inhibitors

Jan. 9, 2020

Merck & Co. identifies new arginase inhibitors

Jan. 9, 2020

Bone Biologics' rhNELL-1 growth factor promotes bone formation in preclinical study

Jan. 9, 2020

FDA clears Carmell's IND for pivotal study of BHA for open tibia fractures

Jan. 9, 2020

Novartis presents new compounds for dengue

Jan. 9, 2020

New treatment discovered for heart tissue scarring after infarct

Jan. 9, 2020

Abbisko Therapeutics divulges FGFR-1 and/or FGFR-2 inhibitors

Jan. 9, 2020

SR-4835, a novel CDK12/13 dual inhibitor for treating triple-negative breast cancer

Jan. 9, 2020

Topline data from pivotal phase II portion of the ACTION-Galactosemia study

Jan. 9, 2020

Positive topline data from phase Ib study of CBP-201 in moderate to severe atopic dermatitis

Jan. 9, 2020

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...